Inventor
ADAM GALAN
Inventor
US
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
A61KPreparations for medical, dental or toiletry purposes10%
C07BGeneral methods of organic chemistry10%
C07CAcyclic or carbocyclic compounds7%
PatentTitleYear
12,595,243Modulators of extracellular signal-regulated kinase202612,404,259Inhibitors of extracellular signal-regulated kinase202512,331,024Substituted naphthyl P38alpha mitogen-activated protein kinase inhibitors202512,269,792Crystalline 5-(dimethylamino)-N-(4-(morpholinomethyl) phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrate202512,116,353Crystalline chloro-n-(4-(morpholinomethyl)phenyl)benzamide and crystalline hydrochloride salt202411,976,049Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitors202411,926,635P38a mitogen-activated protein kinase inhibitors202411,555,020Substituted naphthyl p38a mitogen-activated protein kinase inhibitors202311,440,918p38a mitogen-activated protein kinase inhibitors202211,390,581Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrate202211,286,260P38a mitogen-activated protein kinase inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to GEN1E LIFESCIENCES INC (11)· patent assignee history
2022–2026Based in US· patent location history
2024–2025Patents assigned to GENIE LIFESCIENCES INC (2)· patent assignee history
2025Patents assigned to UNIV MARYLAND (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GEN1E LIFESCIENCES INC | 11 | 2022–2026 |
| GENIE LIFESCIENCES INC | 2 | 2024–2025 |
| UNIV MARYLAND | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 11 | 2022–2026 |